VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CRVSCorvus Pharmaceuticals, Inc.
$13.49$1.1B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksCRVSPrice History

CRVS logoCorvus Pharmaceuticals, Inc. (CRVS) Stock Price History

Historical prices from 2016 to 2026

$13.49+0.44  (+3.37%)close Jun 26
Returns
1M
+5.1%
3M
-4.1%
YTD
+84.3%
1Y
+220.4%
3Y
+87.1%
5Y
+37.1%
ATH$26.95Jan 2026-49.9%
ATL$0.61Mar 2023pre-split
Avg Vol (50D)1.5M/ day
52-Week Range$3.71 — $26.95
LowCurrent: $13.49High

Loading 10-year price history...

CRVS Historical Performance

1 YearTotal Return
+198.4%
Price: +220.4%
3 YearsTotal Return
+528.6%
CAGR: +84.6%
Price: +554.9%
5 YearsTotal Return
+360.9%
CAGR: +35.7%
Price: +383.5%
YTD
+84.3%

CRVS Annual Returns

Year-by-year price performance · 2016–2026

Best+204.0%2024
Worst-67.1%2018
Up years6/11
2016+0.4%
2017-28.2%
2018-67.1%
2019+27.4%
2020-28.7%
2021-36.2%
2022-65.7%
2023+103.0%
2024+204.0%
2025+41.8%
2026+149.5%
2016 annual price return
+0.4%
2017 annual price return
-28.2%
2018 annual price return
-67.1%
2019 annual price return
+27.4%
2020 annual price return
-28.7%
2021 annual price return
-36.2%
2022 annual price return
-65.7%
2023 annual price return
+103.0%
2024 annual price return
+204.0%
2025 annual price return
+41.8%
2026 annual price return
+149.5%
LessMore
Alpha vs S&P 500
1Y+177.5%
3Y+60.0%
5Y+24.5%

Price returns only.

Download Historical Data

2,581 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

CRVS Stock Price Trajectory (2016–2026)

As of June 28, 2026, Corvus Pharmaceuticals, Inc. (CRVS) trades at $13.49, representing a +220.4% return over the past year. The stock has delivered a +360.9% total return over five years (+37.1% CAGR), reflecting significant long-term value creation.

The stock reached its all-time high of $26.95 on January 24, 2026. From this peak, CRVS has corrected -49.9%, currently trading 12% above its 200-day moving average, indicating continued institutional support.

When compared to Healthcare sector peers IMVT (+137.0% 1Y), RCUS (+264.7% 1Y), and TPVG (-32.1% 1Y), CRVS has underperformed the peer group average. Compare CRVS vs IMVT →

CRVS Historical Price Data · from 2016

Rows 1–50 of 2,581
Date Open High Low Close Volume Change %
2026-06-2612.9113.5312.8913.490+3.37%
2026-06-2512.7713.5212.7613.051.29M+0.77%
2026-06-2412.5713.1512.5312.951.01M+2.53%
2026-06-2312.1313.0712.0912.63913K+0.56%
2026-06-2212.4812.7712.2712.561.36M+5.46%
2026-06-1812.3612.5811.7211.911.63M-0.75%
2026-06-1711.8612.3811.8612.001.10M+2.21%
2026-06-1612.3712.4011.6711.741.16M-1.34%
2026-06-1512.0112.3811.8211.90257K-0.25%
2026-06-1211.5212.3211.5011.931.02M+2.84%
2026-06-1111.1811.7010.9111.601.13M+3.94%
2026-06-1011.1311.6210.9911.161.49M-0.09%
2026-06-0911.2411.4910.8311.171.58M+0.18%
2026-06-0811.4711.4711.0411.15893K+0.27%
2026-06-0511.7611.9011.0411.121.15M-5.12%
2026-06-0411.6511.9611.6211.72786K+1.03%
2026-06-0311.7611.8011.3611.601.57M-0.77%
2026-06-0211.8811.9411.4411.691.91M-3.23%
2026-06-0112.1612.3511.8312.081.52M-2.66%
2026-05-2912.5612.8412.0112.412.97M-0.72%
2026-05-2812.9312.9312.2712.501.61M-3.33%
2026-05-2713.5714.0012.7112.931.07M+0.78%
2026-05-2612.7913.2812.5912.83724K+1.74%
2026-05-2212.8213.4312.6012.611.15M-3.59%
2026-05-2112.3513.0912.0913.081.87M+7.30%
2026-05-2011.6712.4411.5412.192.15M+6.00%
2026-05-1912.0712.2711.4311.503.92M-5.81%
2026-05-1812.3712.7011.8012.212.71M-0.81%
2026-05-1513.4713.4712.1912.313.48M-9.85%
2026-05-1415.7015.7913.2113.653.93M-13.79%
2026-05-1315.8216.1415.5515.841.37M-0.81%
2026-05-1215.7216.1215.4415.97889K+1.01%
2026-05-1116.0016.8515.7415.811.14M+1.67%
2026-05-0814.8115.8014.7515.55971K+6.58%
2026-05-0715.3815.3814.5514.591.33M-5.57%
2026-05-0615.8716.2015.4415.45993K-1.59%
2026-05-0516.2416.3715.3415.70276K-2.00%
2026-05-0415.3116.3415.3016.021.09M+3.62%
2026-05-0115.0815.6214.8715.46862K+1.78%
2026-04-3014.5015.3414.4215.19929K+5.34%
2026-04-2915.4115.5514.1114.421.88M-7.68%
2026-04-2815.7716.3115.5015.621.05M-1.88%
2026-04-2716.0816.6815.7515.92782K-1.00%
2026-04-2415.9816.2915.3116.081.27M+0.37%
2026-04-2317.2317.8915.6216.022.21M-10.25%
2026-04-2217.8119.7017.6317.853.36M+4.14%
2026-04-2115.5717.2815.5717.141.47M+10.30%
2026-04-2016.7516.9115.5215.541.23M-7.17%
2026-04-1716.7717.1816.1916.742.47M+11.30%
2026-04-1615.2115.2914.6815.04611K-0.46%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

CRVS — Frequently Asked Questions

Quick answers to the most common questions about buying CRVS stock.

How has CRVS stock performed recently?

CRVS returned +220.4% over the past year, beating its 5-year annualized CAGR of +37.1%. The stock trades above its 200-day moving average, confirming the uptrend.

What is CRVS's all-time high price?

Corvus Pharmaceuticals, Inc. reached $26.95 on 2026-01-24. The 52-week high is $26.95. Current 1-year return of +220.4% places the stock closer to historical peaks.

Where can I download CRVS historical price data?

This page provides CRVS daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2016-2026, downloadable in CSV format.

431 data points · sampled from 2,581